ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,20 (-3,16%)
2026-06-05
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionRhumbline Advisers
Latest Disclosed Ownership362,055 shares
Latest Disclosed Value $ 2,776,950
Rhumbline Advisers reports 10.52% increase in ownership of 26CA / ImmunityBio, Inc.

On May 12, 2026 - Rhumbline Advisers filed a 13F-HR form disclosing ownership of 362,055 shares of ImmunityBio, Inc. (DE:26CA) valued at $2,375,081 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 327,602 shares of ImmunityBio, Inc.. This represents a change in shares of 10.52% during the quarter. The current value of the position is $2,219,397 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F IMMUNITYBIO COM 45256X103 362,055 34,453 10.52 2,777 328.40 0.0024
2026-02-13 2025-12-31 13F IMMUNITYBIO COM 45256X103 327,602 12,979 4.13 649 -16.17 0.0005
2025-11-06 2025-09-30 13F IMMUNITYBIO COM 45256X103 314,623 -19,934 -5.96 774 -12.46 0.0006
2025-08-12 2025-06-30 13F IMMUNITYBIO COM 45256X103 334,557 115,197 52.52 883 33.79 0.0008
2025-05-29 2025-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 219,360 11,573 5.57 660 24.29 0.0006
2025-04-08 2025-03-31 13F IMMUNITYBIO COM 45256X103 219,360 11,573 660 0.0006
2025-05-29 2024-12-31 13F/A-1 IMMUNITYBIO COM 45256X103 207,787 299 0.14 532 -31.13 0.0005
2025-01-30 2024-12-31 13F IMMUNITYBIO COM 45256X103 207,787 299 532 0.0005
2024-11-12 2024-09-30 13F IMMUNITYBIO COM 45256X103 207,488 -4,189 -1.98 772 -42.33 0.0007
2024-08-01 2024-06-30 13F IMMUNITYBIO COM 45256X103 211,677 24,802 13.27 1,338 33.30 0.0013
2024-05-09 2024-03-31 13F IMMUNITYBIO COM 45256X103 186,875 8,035 4.49 1,004 11.82 0.0010
2024-02-08 2023-12-31 13F IMMUNITYBIO COM 45256X103 178,840 37,045 26.13 898 275.31 0.0009
2023-11-09 2023-09-30 13F IMMUNITYBIO COM 45256X103 141,795 -5,350 -3.64 240 -41.56 0.0003
2023-08-08 2023-06-30 13F IMMUNITYBIO COM 45256X103 147,145 35,371 31.65 409 0.0005
2023-05-11 2023-03-31 13F IMMUNITYBIO COM 45256X103 111,774 -830 -0.74 0 -100.00 0.0003
2023-02-14 2022-12-31 13F IMMUNITYBIO COM 45256X103 112,604 3,077 2.81 571 4.96 0.0008
2022-11-10 2022-09-30 13F IMMUNITYBIO COM 45256X103 109,527 8,495 8.41 544 44.68 0.0008
2022-08-11 2022-06-30 13F IMMUNITYBIO COM 45256X103 101,032 12,909 14.65 376 -23.89 0.0005
2022-05-12 2022-03-31 13F IMMUNITYBIO COM 45256X103 88,123 -2,155 -2.39 494 -10.02 0.0006
2022-02-10 2021-12-31 13F IMMUNITYBIO COM 45256X103 90,278 -2,130 -2.30 549 -39.00 0.0007
2021-11-12 2021-09-30 13F IMMUNITYBIO COM 45256X103 92,408 3,268 3.67 900 -29.30 0.0012
2021-08-05 2021-06-30 13F IMMUNITYBIO COM 45256X103 89,140 51,249 135.25 1,273 41.44 0.0017
2021-05-06 2021-03-31 13F IMMUNITYBIO COM 45256X103 37,891 -2,437 -6.04 900 67.29 0.0012
2021-02-10 2020-12-31 13F NANTKWEST INC COM COM 63016Q102 40,328 3,170 8.53 538 108.53 0.0007
2020-11-12 2020-09-30 13F NANTKWEST INC COM COM 63016Q102 37,158 259 0.70 258 -43.05 0.0004
2020-08-13 2020-06-30 13F NANTKWEST INC COM COM 63016Q102 36,899 36,899 453 0.0008
2019-08-14 2019-06-30 13F NANTKWEST INC COM COM 63016Q102 0 -38,052 -100.00 0 -100.00
2019-05-01 2019-03-31 13F NANTKWEST INC COM COM 63016Q102 38,052 -190 -0.50 60 36.36 0.0001
2019-01-31 2018-12-31 13F NANTKWEST INC COM COM 63016Q102 38,242 9,570 33.38 44 -58.49 0.0001
2018-11-07 2018-09-30 13F NANTKWEST INC COM COM 63016Q102 28,672 150 0.53 106 21.84 0.0002
2018-08-06 2018-06-30 13F NANTKWEST INC COM COM 63016Q102 28,522 44 0.15 87 -21.62 0.0002
2018-05-02 2018-03-31 13F NANTKWEST INC COM COM 63016Q102 28,478 -1,040 -3.52 111 -16.54 0.0002
2018-02-09 2017-12-31 13F NANTKWEST INC COM COM 63016Q102 29,518 -5,491 -15.68 133 -30.73 0.0003
2017-11-06 2017-09-30 13F NANTKWEST INC COM COM 63016Q102 35,009 220 0.63 192 -27.27 0.0004
2017-08-02 2017-06-30 13F NANTKWEST INC COM COM 63016Q102 34,789 20,646 145.98 264 428.00 0.0006
2017-05-02 2017-03-31 13F NANTKWEST INC COM COM 63016Q102 14,143 -2,459 -14.81 50 -47.37 0.0001
2017-01-27 2016-12-31 13F NANTKWEST INC COM COM 63016Q102 16,602 737 4.65 95 -22.76 0.0002
2016-11-08 2016-09-30 13F NANTKWEST INC COM COM 63016Q102 15,865 400 2.59 123 28.13 0.0003
2016-08-11 2016-06-30 13F NANTKWEST INC COM COM 63016Q102 15,465 15,465 96 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.